Gene · 3959
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tetraspanin-based immunocapture for high-depth proteomic profiling of extracellular vesicles from cerebrospinal fluid for biomarker discovery. | Clin Proteomics | 2026 | 41547780 | PubTator, text mining | PubMed |
| Effect of Glycated Hemoglobin Levels on Serum Mac-2 Binding Protein Glycosylation Isomer in the Diagnosis of Hepatitis C-Virus Related Hepatic Fibrosis. | J Med Virol | 2026 | 41536202 | PubTator, text mining | PubMed |
| Predictive Value of Serum Autotaxin for Hepatocellular Carcinoma Recurrence After Curative Radiofrequency Ablation. | Cancer Med | 2026 | 41499228 | PubTator, text mining | PubMed |
| Diagnostic Performance of Serum Autotaxin for Staging Liver Fibrosis: A Comparative Study With Other Noninvasive Liver Fibrosis Tests in Chronic Liver Disease. | Hepatol Res | 2026 | 41474388 | PubTator, text mining | PubMed |
| Prognostic Significance of LGALS3BP in Triple-Negative Breast Cancer: Implications for Immune Infiltration and Therapeutic Response. | J Biochem Mol Toxicol | 2026 | 41467329 | PubTator, text mining | PubMed |
| Predictive Value of Serum Mac-2 Binding Protein Glycosylation Isomer for Hepatic Fibrosis in Hepatitis C Virus-Infected Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. | J Gastroenterol Hepatol | 2026 | 41236046 | PubTator, text mining | PubMed |
| Nationwide Trends in Liver Stiffness Measurement in Japan: A Real-World Evidence of NILDA Using the National Database of Health Insurance Claims. | Hepatol Res | 2026 | 41165742 | PubTator, text mining | PubMed |
| Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker. | Mol Oncol | 2026 | 41046347 | PubTator, text mining | PubMed |
| Proteomics-guided Biomarker Discovery, Validation, and Pathway Perturbation in Infection-related Acute Decompensation of Cirrhosis. | Clin Gastroenterol Hepatol | 2026 | 39924007 | PubTator, text mining | PubMed |
| Identifying potential inhibitors against galectin-3-binding protein (LGALS3BP) for therapeutic targeting of glioma. | J Biomol Struct Dyn | 2026 | 39589107 | PubTator, text mining | PubMed |
| [Diagnostic value of serum Mac-2 binding protein for the severity of schistosomiasis-induced liver fibrosis]. | Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi | 2025 | 42046352 | PubTator, text mining | PubMed |
| Pemafibrate as a therapeutic option for metabolic dysfunction-associated steatotic liver disease resistant to dietary intervention. | Clin Exp Hepatol | 2025 | 42021997 | PubTator, text mining | PubMed |
| UKEV Forum 2024: the UK Society for Extracellular Vesicles Annual Meeting - Abstracts. | Extracell Vesicles Circ Nucl Acids | 2025 | 41551612 | PubTator, text mining | PubMed |
| Mesenchymal stem cells derived extracellular vesicles ameliorate ovarian aging through inhibiting LGALS3BP/NF-κB induced inflammation. | J Ovarian Res | 2025 | 41430290 | PubTator, text mining | PubMed |
| Siglec-14-LGALS3BP glycoimmune axis shapes tumor-associated macrophage polarization and confers poor outcome in colorectal cancer. | NPJ Precis Oncol | 2025 | 41398201 | PubTator, text mining | PubMed |
| Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease. | World J Hepatol | 2025 | 41368115 | PubTator, text mining | PubMed |
| Serum Proteomic Profiling Uncovers LGALS3BP as a Potential Biomarker for Idiopathic Pulmonary Arterial Hypertension. | Clin Respir J | 2025 | 41308656 | PubTator, text mining | PubMed |
| Bridging Decades in Cutaneous Immunology-Past Lessons, Present Insights, Future Directions. | Biomedicines | 2025 | 41301807 | PubTator, text mining | PubMed |
| Identification Of Protein Cargo in Extracellular Vesicles from Macrophages in Progressing and Regressing Tumors. | bioRxiv | 2025 | 41279039 | PubTator, text mining | PubMed |
| Evaluation of Antibody-Drug Conjugate Performances Using a Novel HPLC-DAD Method for Tumor-Specific Detection of DM4 and S‑Methyl-DM4. | ACS Omega | 2025 | 41179189 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3959/papers?page=4